Citadel Advisors’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-40,316
| Closed | -$38.5K | – | 7046 |
|
|
2024
Q4 | $38.5K | Buy |
+40,316
| New | +$38.5K | ﹤0.01% | 5519 |
|
|
2024
Q1 | – | Sell |
-51,419
| Closed | -$28.3K | – | 6899 |
|
|
2023
Q4 | $28.3K | Buy |
+51,419
| New | +$28.3K | ﹤0.01% | 5287 |
|
|
2023
Q3 | – | Sell |
-13,149
| Closed | -$34.5K | – | 6600 |
|
|
2023
Q2 | $34.5K | Sell |
13,149
-58,486
| -82% | -$153K | ﹤0.01% | 5112 |
|
|
2023
Q1 | $228K | Buy |
+71,635
| New | +$228K | ﹤0.01% | 4526 |
|